Iovance Biotherapeutics Inc (NASDAQ:IOVA)

31.17
Delayed Data
As of Aug 03
 +1.99 / +6.85%
Today’s Change
17.67
Today|||52-Week Range
41.49
+12.61%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization251.0K252.0K271.0K289.0K
 
 
 
 
 
 
Operating ExpensesGross Income-251.0K-252.0K-271.0K-289.0K
 
 
 
 
 
General Expenses34.8M34.7M39.7M49.9M
 
 
 
 
 
Research And Development27.9M27.4M30.9M39.3M
 
 
 
 
 
Total Operating Expenses35.1M34.9M40.0M50.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-35.1M-34.9M-40.0M-50.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-33.8M-32.6M-37.0M-47.6M
 
 
 
 
 
Net Income-33.8M-32.6M-37.0M-47.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS95.1M119.1M123.4M123.6M
 
 
 
 
 
Shares To Calculate EPS Diluted95.1M119.1M123.4M123.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.36-$0.27-$0.30-$0.38
 
 
 
 
 
EPS Diluted-$0.36-$0.27-$0.30-$0.38